Deborah R Kaye

6PUBLICATIONS
17CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHealth care administration
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 23, 2023
Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer.

Deborah R Kaye, Hui-Jie Lee, Alexander Gordee

|Nov 22, 2022
End-of-Life Care for Patients With Metastatic Renal Cell Carcinoma in the Era of Oral Anticancer Therapy.

Hannah E Dzimitrowicz, Lauren E Wilson, Bradford E Jackson

|May 02, 2022
Association between cognitive impairment and oral anticancer agent use in older patients with metastatic renal cell carcinoma.

Jessica E Pritchard, Lauren E Wilson, Samuel M Miller

|Sep 25, 2018
Pathological upgrading at radical prostatectomy for patients with Grade Group 1 prostate cancer: implications of confirmatory testing for patients considering active surveillance.

Deborah R Kaye, Ji Qi, Todd M Morgan

|Mar 24, 2018
Costs of Cancer Care Across the Disease Continuum.

Deborah R Kaye, Hye Sung Min, Lindsey A Herrel

|Jul 01, 2017
Understanding the relationship between the Centers for Medicare and Medicaid Services' Hospital Compare star rating, surgical case volume, and short-term outcomes after major cancer surgery.

Deborah R Kaye, Edward C Norton, Chad Ellimoottil

Pageof 1

Frequent Collaborators

2 joint publications

Jessica E Pritchard

2 joint publications

Lauren E Wilson

2 joint publications

Melissa A Greiner

2 joint publications

Michaela A Dinan